A 17,000 m2 space dedicated to research, innovation and teaching, which is open to the public.

The new findings were presented at the American Society of Nephrology's Kidney Week 2024 meeting in San Diego and simultaneously published in the prestigious journal Nature Medicine.

A new consortium of leading organizations embarks on a groundbreaking project to enhance patient triage and healthcare delivery.

Over time, wild boars have approached the city of Barcelona and surrounding areas. As carriers of the hepatitis E virus, they are linked to a study identifying them as a potential source of transmission of this disease.

During the meeting, the role of the Vall d'Hebron Paediatric Research Hub in promoting research on children and adolescents was highlighted.

The new technology allows more sensitive detection of scleroderma patients' autoantibodies, which are related to the severity and progression of the disease.

The meeting was an opportunity to get to know projects from both institutions and to promote interaction between professionals.

The Experimental Surgery Unit and the Preclinical Imaging Platform of VHIR will host several practical classes of the module "Reduction and Refinement in Experimental Design and Methodology," of the Master's in Laboratory Animal Science and Welfare

The communication is part of a study aimed at identifying the mechanisms of progression of Familial Hypomagnesemia with Hypercalciuria and Nephrocalcinosis, a rare disease that affects the kidneys.

The study on the effects of diesel particles on the heart has been recognized as the best research work from Spain at the association’s Scientific Sessions.

On European Antibiotic Awareness Day, we highlight the importance of using these medications responsibly and finding innovative solutions to combat this issue.

The experience of our teaching staff and research groups, the commitment to professional development and the tutorial action plan are highlighted.

A study jointly led by the Hospital Clínic of Barcelona and the Vall d'Hebron Research Institute (VHIR) confirms the effectiveness of neonatal screening in reducing morbidity among children with sickle cell disease (SCD).

This appointment is an international recognition of VHIR's immunodeficiency research.

Active participation by patients and families in studies helps identify more effective therapies that improve quality of life and survival.

Vall d'Hebron has coordinated this initiative that has carried out numerous training and community awareness activities aimed at empowering young people in sexual and reproductive health issues.

Hybrids VITA, developed together with Medical Simulator, reproduces different clinical scenarios for training on how to prevent, diagnose and treat possible complications of ECMO, which is a very complex technique.

The conclusions from the 1st International Congress on Health Communication will provide the basis for a Guide to Health Communication, which will be share with the European University Hospital Alliance (EUHA).

Practical workshops and the Meet the Expert session, so that attendees could interact directly with some of the speakers, complete the round tables.

One of the most important projects of this joint endeavour is the ‘No estic sol’ project for children and adults: a benchmark care model for minority illnesses which, under the leadership of Vall d'Hebron, has already been extended to other centres.

More than 400 professionals from the fields of health, communication, and political institutions exchange reflections and experiences. Experts warn about the impact of misinformation and the need for transparent and effective communication

A study by the Infectious Diseases group at VHIR has found that some people with HIV can uniquely control the virus thanks to a special type of cell in their immune system.

The awarded projects will study the immune response to HIV and the VIGex tool as a biomarker for immunotherapy response.

Extracorporeal Cardiopulmonary Resuscitation (ECPR) offers therapeutic options for patients in whom conventional cardiopulmonary resuscitation techniques fail to restore the heartbeat.